Boston Scientific Corp. said on Monday it offered to buy medical-device maker Guidant Corp. for about $25 billion in cash and stock, topping an offer from Johnson & Johnson.
Boston Scientific said it was offering $72 a share, a premium of about 14 percent over the $63.43 offered under a revised, lesser-valued deal between Guidant and Johnson & Johnson, and a 16 percent premium over Guidant’s closing stock price on Friday.
